Hank Mansbach
2023
In 2023, Hank Mansbach earned a total compensation of $2.5M as Chief Medical Officer at 89bio, a 66% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $243,900 |
|---|---|
| Option Awards | $1,368,516 |
| Salary | $483,000 |
| Stock Awards | $441,000 |
| Other | $5,971 |
| Total | $2,542,387 |
Mansbach received $1.4M in option awards, accounting for 54% of the total pay in 2023.
Mansbach also received $243.9K in non-equity incentive plan, $483K in salary, $441K in stock awards and $6K in other compensation.
Rankings
In 2023, Hank Mansbach's compensation ranked 381st out of 3,006 executives tracked by ExecPay. In other words, Mansbach earned more than 87.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 381 out of 3,006 | 87th |
Division Manufacturing | 217 out of 1,650 | 87th |
Major group Chemicals And Allied Products | 151 out of 918 | 84th |
Industry group Drugs | 148 out of 881 | 83rd |
Industry Pharmaceutical Preparations | 90 out of 637 | 86th |
Source: SEC filing on April 17, 2024.
Mansbach's colleagues
We found two more compensation records of executives who worked with Hank Mansbach at 89bio in 2023.
News
89bio CEO Rohan Palekar's 2023 pay jumps 79% to $5.6M
April 17, 2024
89bio CEO Rohan Palekar's 2022 pay falls 36% to $3.1M
April 24, 2023
89bio CEO Rohan Palekar's 2021 pay rises 1% to $4.9M
April 14, 2022
89bio CEO Rohan Palekar's 2020 pay jumps 378% to $4.9M
April 15, 2021
89bio CEO Rohan Palekar's 2019 pay jumps 44% to $1M
May 8, 2020